94 related articles for article (PubMed ID: 23978076)
1. Functionalization of small rigid platforms with cyclic RGD peptides for targeting tumors overexpressing αvβ3-integrins.
Morlieras J; Dufort S; Sancey L; Truillet C; Mignot A; Rossetti F; Dentamaro M; Laurent S; Vander Elst L; Muller RN; Antoine R; Dugourd P; Roux S; Perriat P; Lux F; Coll JL; Tillement O
Bioconjug Chem; 2013 Sep; 24(9):1584-97. PubMed ID: 23978076
[TBL] [Abstract][Full Text] [Related]
2. In vivo optical imaging of integrin alphaV-beta3 in mice using multivalent or monovalent cRGD targeting vectors.
Jin ZH; Josserand V; Foillard S; Boturyn D; Dumy P; Favrot MC; Coll JL
Mol Cancer; 2007 Jun; 6():41. PubMed ID: 17565663
[TBL] [Abstract][Full Text] [Related]
3. Cyclic RGD peptide-labeled upconversion nanophosphors for tumor cell-targeted imaging.
Zako T; Nagata H; Terada N; Utsumi A; Sakono M; Yohda M; Ueda H; Soga K; Maeda M
Biochem Biophys Res Commun; 2009 Mar; 381(1):54-8. PubMed ID: 19351594
[TBL] [Abstract][Full Text] [Related]
4. High contrast upconversion luminescence targeted imaging in vivo using peptide-labeled nanophosphors.
Xiong L; Chen Z; Tian Q; Cao T; Xu C; Li F
Anal Chem; 2009 Nov; 81(21):8687-94. PubMed ID: 19817386
[TBL] [Abstract][Full Text] [Related]
5. A novel solid lipid nanoparticle formulation for active targeting to tumor α(v) β(3) integrin receptors reveals cyclic RGD as a double-edged sword.
Shuhendler AJ; Prasad P; Leung M; Rauth AM; Dacosta RS; Wu XY
Adv Healthc Mater; 2012 Sep; 1(5):600-8. PubMed ID: 23184795
[TBL] [Abstract][Full Text] [Related]
6. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
Morales-Avila E; Ferro-Flores G; Ocampo-García BE; De León-Rodríguez LM; Santos-Cuevas CL; García-Becerra R; Medina LA; Gómez-Oliván L
Bioconjug Chem; 2011 May; 22(5):913-22. PubMed ID: 21513349
[TBL] [Abstract][Full Text] [Related]
7. Cyclic RGD peptides interfere with binding of the Helicobacter pylori protein CagL to integrins αVβ3 and α5β1.
Conradi J; Huber S; Gaus K; Mertink F; Royo Gracia S; Strijowski U; Backert S; Sewald N
Amino Acids; 2012 Jul; 43(1):219-32. PubMed ID: 21915696
[TBL] [Abstract][Full Text] [Related]
8. Functionalized cyclic RGD peptidomimetics: conjugable ligands for αvβ3 receptor imaging.
Arosio D; Manzoni L; Araldi EM; Caprini A; Monferini E; Scolastico C
Bioconjug Chem; 2009 Aug; 20(8):1611-7. PubMed ID: 21141806
[TBL] [Abstract][Full Text] [Related]
9. Cyclic RGD functionalized gold nanoparticles for tumor targeting.
Arosio D; Manzoni L; Araldi EM; Scolastico C
Bioconjug Chem; 2011 Apr; 22(4):664-72. PubMed ID: 21434651
[TBL] [Abstract][Full Text] [Related]
10. The relationship between the cyclic-RGDfK ligand and αvβ3 integrin receptor.
Mondal G; Barui S; Chaudhuri A
Biomaterials; 2013 Aug; 34(26):6249-60. PubMed ID: 23702147
[TBL] [Abstract][Full Text] [Related]
11. Fluorescence reflectance imaging of macrophage-rich atherosclerotic plaques using an alphavbeta3 integrin-targeted fluorochrome.
Waldeck J; Häger F; Höltke C; Lanckohr C; von Wallbrunn A; Torsello G; Heindel W; Theilmeier G; Schäfers M; Bremer C
J Nucl Med; 2008 Nov; 49(11):1845-51. PubMed ID: 18927332
[TBL] [Abstract][Full Text] [Related]
12. Mesoporous silica nanoparticles functionalized with fluorescent and MRI reporters for the visualization of murine tumors overexpressing αvβ3 receptors.
Hu H; Arena F; Gianolio E; Boffa C; Di Gregorio E; Stefania R; Orio L; Baroni S; Aime S
Nanoscale; 2016 Apr; 8(13):7094-104. PubMed ID: 26960989
[TBL] [Abstract][Full Text] [Related]
13. Targeting tumors with cyclic RGD-conjugated lipid nanoparticles loaded with an IR780 NIR dye: In vitro and in vivo evaluation.
Choi J; Rustique E; Henry M; Guidetti M; Josserand V; Sancey L; Boutet J; Coll JL
Int J Pharm; 2017 Nov; 532(2):677-685. PubMed ID: 28279737
[TBL] [Abstract][Full Text] [Related]
14. Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125.
Kim YH; Jeon J; Hong SH; Rhim WK; Lee YS; Youn H; Chung JK; Lee MC; Lee DS; Kang KW; Nam JM
Small; 2011 Jul; 7(14):2052-60. PubMed ID: 21688390
[TBL] [Abstract][Full Text] [Related]
15. Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies.
Guzzetti I; Civera M; Vasile F; Araldi EM; Belvisi L; Gennari C; Potenza D; Fanelli R; Piarulli U
Org Biomol Chem; 2013 Jun; 11(23):3886-93. PubMed ID: 23657523
[TBL] [Abstract][Full Text] [Related]
16. Multivalent cyclic RGD ligands: influence of linker lengths on receptor binding.
Kubas H; Schäfer M; Bauder-Wüst U; Eder M; Oltmanns D; Haberkorn U; Mier W; Eisenhut M
Nucl Med Biol; 2010 Nov; 37(8):885-91. PubMed ID: 21055618
[TBL] [Abstract][Full Text] [Related]
17. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
18. Tumor targeting of functionalized lipid nanoparticles: assessment by in vivo fluorescence imaging.
Goutayer M; Dufort S; Josserand V; Royère A; Heinrich E; Vinet F; Bibette J; Coll JL; Texier I
Eur J Pharm Biopharm; 2010 Jun; 75(2):137-47. PubMed ID: 20149869
[TBL] [Abstract][Full Text] [Related]
19. Cyclic RGD peptide-conjugated polyplex micelles as a targetable gene delivery system directed to cells possessing alphavbeta3 and alphavbeta5 integrins.
Oba M; Fukushima S; Kanayama N; Aoyagi K; Nishiyama N; Koyama H; Kataoka K
Bioconjug Chem; 2007; 18(5):1415-23. PubMed ID: 17595054
[TBL] [Abstract][Full Text] [Related]
20. Carbodiimide versus click chemistry for nanoparticle surface functionalization: a comparative study for the elaboration of multimodal superparamagnetic nanoparticles targeting αvβ3 integrins.
Bolley J; Guenin E; Lievre N; Lecouvey M; Soussan M; Lalatonne Y; Motte L
Langmuir; 2013 Nov; 29(47):14639-47. PubMed ID: 24171381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
